CYBB and congestive heart failure: It, therefore, seems plausible that such candidates may represent potential pharmacological targets to support more effective clinical treatment of CHF, although further investigation is clearly required to confirm roles of specific cytokines and to define detailed inflammatory pathways underlying Nox2-dependent PPARα signalling in this setting.